Study on How Parents' Anticipated Choice of a Doctor at the Maternity Hospital Influences the Newborn's First Post-discharge Consultation

NCT ID: NCT07329192

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-13

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to determine whether, in a population of well-informed parents, choosing a general practitioner at the maternity hospital facilitates the completion of the newborn's first required medical examination within the second week of life.

The main question it aims to answer is: Does selecting a general practitioner before leaving the maternity hospital allow the newborn's first medical examination to be completed within the recommended period?

Participants will be asked to complete an initial questionnaire, which will be given to them before leaving the maternity hospital, and then a second questionnaire by telephone one month later.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For eligible newborns, an information sheet will be provided to the parents or legal guardians.

Parents or legal guardians who have been informed of the study and do not object to their child's participation will receive a questionnaire between the second postnatal day (D2) and discharge from the maternity ward.

Each completed questionnaire will be collected prior to discharge. The research team will then contact the parents by telephone on day 30 (±3 days) to administer the second questionnaire and record their responses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Newborn Infant Newborn

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

newborn

newborn

Advance Selection of a General Practitioner

Intervention Type OTHER

This exposure refers to parents selecting a general practitioner for their newborn before discharge from the maternity hospital.

It represents a routine-care organizational choice that may influence whether the first post-discharge medical examination is completed within the recommended period. No study-specific procedures or treatments are administered.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Advance Selection of a General Practitioner

This exposure refers to parents selecting a general practitioner for their newborn before discharge from the maternity hospital.

It represents a routine-care organizational choice that may influence whether the first post-discharge medical examination is completed within the recommended period. No study-specific procedures or treatments are administered.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Term newborn ≥ 37 weeks of gestation
* Birth weight \> 3000 g
* Growth \> 5th percentile according to Fenton curves
* No diagnosed or suspected pathology during antenatal care or the maternity stay
* No postnatal complications requiring temporary hospitalization in the neonatal unit or kangaroo care unit

Exclusion Criteria

* Pathology diagnosed or suspected in the newborn during the maternity hospital stay.
* Requirement for temporary hospitalization in a neonatal unit or kangaroo care unit, including but not limited to: neonatal jaundice, abnormal oxygenation or laboratory findings, suspected early-onset bacterial infection, transient respiratory distress requiring more than 2 hours of non-invasive ventilation at birth, monitoring of mother-infant bonding, or maternal treatments during pregnancy necessitating clinical monitoring.
* Language barrier in both parents.
* Parents (legal guardians) informed of the study and having declined participation for themselves and their child.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Sud Francilien

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marion BATHANY, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Sud Francilien

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, France, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marion BATHANY, MD

Role: CONTACT

01 61 69 77 38 ext. +33

Caroline TOURTE

Role: CONTACT

01 61 69 31 50 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Caroline TOURTE

Role: primary

01 61 69 31 50 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025/0045

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Delivery Room Skin-to-skin Study
NCT01959737 COMPLETED NA